University of Missouri-Columbia
The purpose of this study is to find out how the language of people with Primary Progressive Aphasia is affected by Propranolol. Propranolol is not FDA approved for the treatment of Primary Progressive Aphasia. Propranolol is FDA approved for the treatment of heart conditions such as blood pressure. This research is being done because there are currently no drug treatment options for language impairments and anxiety often experienced by people with Primary Progressive Aphasia.
Inclusion Criteria: * 1\. Age: 50 and older * 2\. Primary Progressive Aphasia diagnosis * 3\. Native English speaker Exclusion Criteria: * 1\. Unable to provide consent * 2\. Taking alpha 2 agonists (clonidine and guanfacine) * 3\. Other major psychological or neurological diagnosis * 4\. Major head trauma that contributed to their condition * 5\. Allergic reaction to adhesives * 6\. Uncorrected vision/hearing impairments * 7\. Diabetes * 8\. Reactive airway disease * 9\. Untreated hypothyroidism * 10\. Bradyarrhythmia * 11\. Unexplained syncope * 12\. Pregnancy (assessed verbally on the da…
Propranolol will be given on a titration schedule in which participants will begin with small doses of the drug and increase to a larger dosage over the course of three weeks. Propranolol will be taken for a total of 9 weeks.
Magnetic Resonance Imaging (MRI) will be performed at 3 Tesla and 7 Tesla, for both propranolol and placebo arms.
Placebo will be given on the same schedule as the propranolol regime.
Arctuva estimate
Verify or correct the compensation shown for this listing.